EUVIMEDEUVIMED entdecken
Klinische StudieKlinische Studie (Phase I)Klinische Studie (Phase II)

No Evidence of IFN-γ Increase in the Serum of HIV-Positive and Healthy Subjects after Subcutaneous Injection of a Non-Fermented Viscum album L. Extract

M Stoss, R W Gorter

Natural Immunity · 1998

DOI: 10.1159/000069440 ↗

Kurz gefasst

Klinische Studie in der Zeitschrift Natural Immunity, 1998. Verfasst von M Stoss und 1 weiteren Autor:innen. Beteiligte Einrichtung: European Institute for Oncological and Immunological Research, Berlin, Germany. Hauptthemen laut MEDLINE: Plant Proteins. Die Arbeit wurde bisher 4-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Iscador®, an aqueous extract of Viscum album L., has been used for more than 80 years as an anticancer drug. Due to its immunomodulatory potential, since the onset of the AIDS epidemic it has also been applied in the treatment of HIV-positive and AIDS patients in the form of the preparation V. album QuFrF (VaQuFrF; Labor Hiscia, Arlesheim, Switzerland). In in vitro investigations, incubation of peripheral blood mononuclear cells with V. album L. extracts resulted in stimulation of lymphocyte activity with increased gene expression and release of various cytokines and also of interferon gamma (IFN-γ). In the latent phase, HIV positives exhibit only slightly elevated IFN-γ concentrations in serum in comparison with HIV negatives, but in the acute phase of AIDS, there is an increase in levels of IFN-γ. As the assay of cytokine levels in serum is a simple method of measuring immune system reactions, the aim of this trial was to determine whether increases in serum IFN-γ levels in HIV positives and HIV negatives can be detected using this method after repeated injections of VaQuFrF. Five healthy subjects and 13 HIV-positive patients were investigated. IFN-γ concentrations in serum were assayed using an ELISA test kit (ELISA test; ENDOGEN, Cambridge, Mass., USA). No drug-related elevation of serum IFN-γ was observed at any time point during the trial. It can thus be concluded that this method is not suitable for direct investigation of the immunomodulatory effects of VaQuFrF in vivo.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Plant ProteinsAdjuvants, ImmunologicAdultFemaleHIV SeropositivityHumansInjections, SubcutaneousInterferon-gammaMaleMiddle AgedMistletoePlant ExtractsPlants, Medicinal

Substanzen

Adjuvants, ImmunologicPlant ExtractsPlant ProteinsInterferon-gammaviscum album peptide

Autor:innen und Institutionen

  • European Institute for Oncological and Immunological Research, Berlin, Germany.

Zitieren

APA

Stoss, M., & Gorter, R. W. (1998). No Evidence of IFN-γ Increase in the Serum of HIV-Positive and Healthy Subjects after Subcutaneous Injection of a Non-Fermented Viscum album L. Extract. Natural Immunity. https://doi.org/10.1159/000069440

Vancouver

Stoss M, Gorter RW. No Evidence of IFN-γ Increase in the Serum of HIV-Positive and Healthy Subjects after Subcutaneous Injection of a Non-Fermented Viscum album L. Extract. Natural Immunity. 1998. doi:10.1159/000069440

BibTeX
@article{Stoss1998,
  author = {Stoss, M and Gorter, R W},
  title = {No Evidence of IFN-γ Increase in the Serum of HIV-Positive and Healthy Subjects after Subcutaneous Injection of a Non-Fermented Viscum album L. Extract},
  journal = {Natural Immunity},
  year = {1998},
  doi = {10.1159/000069440}
}
Kostenlos starten →